Alex Mascioli

ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer

Retrieved on: 
Wednesday, January 24, 2024
Hyperuricemia, CMC, Therapy, DRS, PEG, Alex Mascioli, IND, Family, Cornell University, Polymer, FDA, Gout, Friends, Pharmacokinetics, Publication, Gel, Pharmaceutical industry

Larry Miller and Ron Cohen as Independent Directors to the company's Board of Directors, and Dr. Ed Mascioli as Chief Executive Officer and Board Director.

Key Points: 
  • Larry Miller and Ron Cohen as Independent Directors to the company's Board of Directors, and Dr. Ed Mascioli as Chief Executive Officer and Board Director.
  • Ed Mascioli's significant experience leading multiple biotech companies is important in our Company's growth" said Dr. Shaoyi Jiang, the Robert Langer '70 Family and Friends Professor at Cornell University, ZWI Board member, and co-founder.
  • "As board members, Ron and Larry collectively bring decades of successful pharmaceutical industry experience to ZWI.
  • ZWI has gained meaningful guidance on CMC, non-clinical, and clinical plans from the FDA via an INTERACT meeting and is progressing toward filing an IND.

Quantreq CEO Alex Mascioli to be Featured Speaker at North American Fund Administration Association September Reception

Retrieved on: 
Tuesday, September 11, 2018
Finance, Money, Alex Mascioli

NEW YORK, Sept. 11, 2018 /PRNewswire/ -- Quantreq Capital Markets, LLC Chief Executive Officer Alex Mascioli will be the featured speaker at the North American Fund Administration Association reception held in New York City.

Key Points: 
  • NEW YORK, Sept. 11, 2018 /PRNewswire/ -- Quantreq Capital Markets, LLC Chief Executive Officer Alex Mascioli will be the featured speaker at the North American Fund Administration Association reception held in New York City.
  • The morning reception held by NAFAA will take place September 13th at 350 Park Avenue.
  • Mr. Mascioli will discuss topics pertaining to the administration of crypto funds which will include; Onboarding, fund setup, currency classes, fees & valuations, investor services, treasury banking, digital asset custody and accounting & financial reporting from multiple exchanges.
  • The September reception is open to fund administration executives only.